The changes to the Meta performance review system bring new rewards for top performers, while also increasing the frequency ...

As the end of the year approaches, many workers are steeling themselves for their annual performance review. Performance reviews can be intimidating, but they can also be valuable opportunities to ...

In 2025, my biotech-focused portfolio delivered a 34.3% average return, outperforming the S&P 500 by 20.6%. I prioritize small- and mid-cap biotechs with FDA-approved drugs entering commercialization, ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Jyoti Mann Every time Jyoti publishes a story, you’ll get an alert straight to your inbox!